TrialBritish journal of cancer2016

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.

Avinash Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.